Section 165A(3)
[SCHEDULE 12AE+WPharmaceutical remuneration
InterpretationE+W
1E+WIn this Schedule—
(a)“drugs” includes medicines and listed appliances (within the meaning of section 126), and
(b)“pharmaceutical remuneration” means remuneration paid by [NHS England] to persons providing pharmaceutical services or local pharmaceutical services.
Pharmaceutical remuneration to be apportioned among [integrated care boards]E+W
2(1)[NHS England] must determine the elements of pharmaceutical remuneration in respect of which apportionments are to be made in relation to a financial year in accordance with this paragraph.E+W
(2)In this Schedule, those elements of pharmaceutical remuneration are referred to as “designated elements”.
(3)[NHS England] must notify each [integrated care board] of a determination under sub-paragraph (1).
(4)[NHS England] must apportion the sums paid by it in respect of each designated element during the financial year among all [integrated care boards], in such manner as [NHS England] thinks appropriate.
(5)In apportioning sums under sub-paragraph (4), [NHS England] may, in particular, take into account the financial consequences of orders for the provision of drugs that are attributable to the members of each [integrated care board].
(6)Where an amount of pharmaceutical remuneration is apportioned to [an integrated care board], [NHS England]—
(a)may deduct that amount from the sums that it would otherwise pay to [the board] under section 223G(1), and
(b)if it does so, must notify [the board] accordingly.
(7)The Secretary of State may direct [NHS England] that an element of pharmaceutical remuneration specified in the direction is not to be included in a determination under sub-paragraph (1).
(8)In determining the amount to be allotted to [an integrated care board] for the purposes of section 223G, [NHS England] must take into account the effect of this Schedule.
[(9)For the purposes of sections 223GC and 223M(1)(b) and paragraph 22 of Schedule 1B, any amount of which an integrated care board is notified under sub-paragraph (6) is to be treated as expenditure of the group which is attributable to the performance by it of its functions in the year in question.]
Other pharmaceutical remunerationE+W
3(1)This paragraph applies in relation to pharmaceutical remuneration paid in a financial year other than—E+W
(a)designated elements of such remuneration, and
(b)remuneration of a prescribed description.
(2)[NHS England] may require a person to reimburse [NHS England] for any pharmaceutical remuneration to which this paragraph applies if the drugs or services to which the remuneration relates were—
(a)ordered by that person, or
(b)ordered in the course of the delivery of a service arranged by that person.
(3)Any sum payable to [NHS England] by virtue of sub-paragraph (2) may be recovered summarily as a civil debt (but this does not affect any other method of recovery).
Exercise of functionsE+W
4E+W[NHS England] may, with the consent of the Secretary of State—
(a)direct a Special Health Authority to exercise any functions of [NHS England] under this Schedule, or
(b)arrange for any other person to exercise any of those functions.]